title: Ultrasound-guided thrombin injection is the treatment of choice for femoral pseudoaneurysms.
abstract: OBJECTIVE
  Ultrasound-guided injection of thrombin is the treatment of choice for femoral pseudoaneurysms.
  
  
  METHODS
  A prospective study of patients undergoing a single form of treatment for femoral pseudoaneurysms.
  
  
  METHODS
  Patients were treated at 2 tertiary care, university-affiliated hospitals.
  
  
  METHODS
  Forty consecutive patients with femoral pseudoaneurysms resulting from diagnostic and therapeutic catheterizations for peripheral arterial, coronary arterial, and cerebrovascular diseases were evaluated.
  
  
  METHODS
  Thrombin was injected directly into the pseudoaneurysms under ultrasonographic guidance.
  
  
  METHODS
  Thrombosis of the pseudoaneurysm following thrombin injection was the goal of treatment.
  
  
  RESULTS
  All 40 patients had initial complete thrombosis of their femoral pseudoaneurysms. In each case, except for one, the aneurysm was noted to have thrombosed on follow-up duplex ultrasonogram. There was one complication.
  
  
  CONCLUSIONS
  Ultrasound-guided thrombin injection is the treatment of choice for femoral pseudoaneurysms.
authors.affiliation: Division of Vascular Surgery, North Shore University Hospital, 300 Community Dr, Manhasset, NY, USA. sfried@nshs.edu
authors.forename: Steven G
authors.initials: SG
authors.lastname: Friedman
authors.forename: John S
authors.initials: JS
authors.lastname: Pellerito
authors.forename: Larry
authors.initials: L
authors.lastname: Scher
authors.forename: Glenn
authors.initials: G
authors.lastname: Faust
authors.forename: Brian
authors.initials: B
authors.lastname: Burke
authors.forename: Toufic
authors.initials: T
authors.lastname: Safa
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017541:Aneurysm, False / Q000000981:diagnostic imaging / Q000209:etiology / Q000628:therapy*; D005260:Female; D005263:Femoral Artery; D006490:Hemostatics / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007049:Iatrogenic Disease; D007269:Injections, Intra-Arterial / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D013917:Thrombin / Q000008:administration & dosage* / Q000009:adverse effects; D018617:Ultrasonography, Doppler, Pulsed; D018084:Ultrasonography, Interventional
chemical_list: D006490:Hemostatics; D013917:Thrombin